Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment

AIMS: Renal disease is a frequent comorbidity of type 2 diabetes mellitus (T2DM) and an important factor complicating the choice of glucose-lowering drugs. The aim of this analysis was to evaluate the efficacy and safety of the dipeptidyl peptidase (DPP)-4 inhibitor linagliptin (5 mg/day) in mono, d...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetes Obes Metab
Main Authors: Groop, P-H, Del Prato, S, Taskinen, M-R, Owens, D R, Gong, Y, Crowe, S, Patel, S, von Eynatten, M, Woerle, H-J
Format: Artigo
Sprog:Inglês
Udgivet: Blackwell Publishing Ltd 2014
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4288982/
https://ncbi.nlm.nih.gov/pubmed/24612167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12281
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker